Search results for "NCT"

showing 10 items of 16712 documents

Mild Parkinsonian Signs in a Hospital-based Cohort of Mild Cognitive Impairment Types: A Cross-sectional Study

2018

Background:Mild Parkinsonian Signs (MPS) have been associated with Mild Cognitive Impairment (MCI) types with conflicting results.Objective:To investigate the association of individual MPS with different MCI types using logistic ridge regression analysis, and to evaluate for each MCI type, the association of MPS with caudate atrophy, global cerebral atrophy, and the topographical location of White Matter Hyperintensities (WMH), and lacunes.Methods:A cross-sectional study was performed among 1,168 subjects with different types of MCI aged 45-97 (70,52 ± 9,41) years, who underwent brain MRI. WMH were assessed through two visual rating scales. The number and location of lacunes were also rated…

0301 basic medicineApolipoprotein EMalemedicine.medical_specialtyMild parkinsonian signsbehavioral disciplines and activitiesCohort Studies03 medical and health sciencesLateral ventricles0302 clinical medicineAtrophyParkinsonian DisordersRating scaleInternal medicinemental disordersmedicineDementiaHumansCognitive Dysfunctioncaudate atrophyProspective cohort studyAgedglobal cerebral atrophyCerebral atrophyAged 80 and overbusiness.industryMiddle Agedwhite matter hyperintensitiesmedicine.diseaseHyperintensitynervous system diseases030104 developmental biologyCross-Sectional StudiesNeurologyCardiologyFemaleNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Assembly rules of helminth parasite communities in grey mullets: combining components of diversity.

2020

Abstract Organisms aggregate in ecological communities. It has been widely debated whether these associations are explained by deterministic or, in contrast, random processes. The answer may vary, depending on the level of an organisational scale (α, β and γ) and the facet of diversity considered: taxonomic, functional and phylogenetic. Diversity at the level of a sampling unit (i.e. host individual) is the α diversity; β diversity represents the extent of dissimilarity in diversity among sampling units (within a level of an organisational scale, β1; between levels of an organisational scale, β2); and the total diversity of a system is γ diversity. Thus, the combination of facets and levels…

0301 basic medicineAssembly rules030231 tropical medicineBiology03 medical and health sciencesFunctional diversity0302 clinical medicineLimiting similarityHelminthsMediterranean SeaHelminthsParasite hostingAnimals[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology14. Life underwaterPhylogenyPhylogenetic treeEcologyrespiratory systemSmegmamorphaPhylogenetic diversity030104 developmental biologyInfectious DiseasesTraitParasitology[SDE.BE]Environmental Sciences/Biodiversity and Ecologyhuman activitiesInternational journal for parasitology
researchProduct

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia

2020

Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is characterized by degeneration of the large sensory neurons and spinocerebellar tracts, cardiomyopathy, and increased incidence in diabetes. The underlying pathophysiological mechanism of FRDA, driven by a significantly decreased expression of frataxin (FXN), involves increased oxidative stress, reduced activity of enzymes containing iron‑sulfur clus-ters (ISC), defective energy production, calcium dyshomeostasis, and impaired mitochondrial biogenesis, leading to mitochondrial dysfunction. The peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated transcriptional factor playing a key role in mito…

0301 basic medicineAtaxiaCell SurvivalCaspase 3PPAR agonistlcsh:RC321-57103 medical and health sciencesMice0302 clinical medicineIron-Binding ProteinsmedicineNeuritesAnimalsHumansMyocytes CardiacNeurodegenerationDorsal root ganglia neuronslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryMembrane Potential MitochondrialNeuronsCardiomyocytesbiologyChemistryFrataxinNeurodegenerationCalpainLipid DropletsPeroxisomemedicine.diseaseCell biologyMitochondriaRatsPPAR gamma030104 developmental biologyNeurologyMitochondrial biogenesisFriedreich AtaxiaFrataxinbiology.proteinThiazolidinedionesmedicine.symptomMitochondrial function030217 neurology & neurosurgery
researchProduct

Drosophila melanogaster Models of Friedreich's Ataxia

2018

Friedreich’s ataxia (FRDA) is a rare inherited recessive disorder affecting the central and peripheral nervous systems and other extraneural organs such as the heart and pancreas. This incapacitating condition usually manifests in childhood or adolescence, exhibits an irreversible progression that confines the patient to a wheelchair, and leads to early death. FRDA is caused by a reduced level of the nuclear-encoded mitochondrial protein frataxin due to an abnormal GAA triplet repeat expansion in the first intron of the humanFXNgene.FXNis evolutionarily conserved, with orthologs in essentially all eukaryotes and some prokaryotes, leading to the development of experimental models of this dis…

0301 basic medicineAtaxialcsh:MedicineDiseaseReview ArticleBiologyGeneral Biochemistry Genetics and Molecular BiologyPathogenesis03 medical and health sciences0302 clinical medicinemedicineGeneGeneticsGeneral Immunology and Microbiologylcsh:RIntronGeneral Medicinebiology.organism_classification030104 developmental biologyFrataxinbiology.proteinSistema nerviós MalaltiesDrosophila melanogastermedicine.symptomGenètica030217 neurology & neurosurgeryFunction (biology)BioMed Research International
researchProduct

Dual Function Molecules and Processes in Cell Fate Decision: A Preface to the Special Issue

2020

A lot of water has passed under the bridge since 1999, when C.J. Jeffery stated in a pioneering review that “the idea of one gene-one protein-one function has become too simple” [...]

0301 basic medicineBiologyCatalysisInorganic Chemistrylcsh:Chemistry03 medical and health sciences0302 clinical medicineSettore BIO/10 - BiochimicaAnimalsHumanscell fate decisionPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyDual functiondouble-faced molecules and processesOrganic ChemistryGene Expression Regulation DevelopmentalCell DifferentiationGeneral MedicineComputer Science Applications030104 developmental biologyEditorialn/alcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisNeuroscienceSignal TransductionInternational Journal of Molecular Sciences
researchProduct

GABA and Gap Junctions in the Development of Synchronized Activity in Human Pluripotent Stem Cell-Derived Neural Networks.

2017

The electrical activity of the brain arises from single neurons communicating with each other. However, how single neurons interact during early development to give rise to neural network activity remains poorly understood. We studied the emergence of synchronous neural activity in human pluripotent stem cell (hPSC)-derived neural networks simultaneously on a single-neuron level and network level. The contribution of gamma-aminobutyric acid (GABA) and gap junctions to the development of synchronous activity in hPSC-derived neural networks was studied with GABA agonist and antagonist and by blocking gap junctional communication, respectively. We characterized the dynamics of the network-wide…

0301 basic medicineBiolääketieteet - Biomedicineneural networkstem cell derived neuronslcsh:RC321-57103 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineCalcium imagingPremovement neuronal activityhuman pluripotent stem cellsInduced pluripotent stem celllcsh:Neurosciences. Biological psychiatry. Neuropsychiatrygap junctionsOriginal ResearchArtificial neural networkGABAA receptorChemistrymicroelectrode arrayGap junctionsynchronyDepolarizationMultielectrode arraycalcium imaging030104 developmental biologynervous systemexcitatory GABANeuroscienceNeurotieteet - Neurosciences030217 neurology & neurosurgeryNeuroscienceFrontiers in cellular neuroscience
researchProduct

Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus

2021

Diabetes represents the leading risk factor for the development of cardiovascular disease (CVD). Chronic hyperglycemia and/or acute post-prandial changes in blood glucose determine an increase in reactive oxygen species (ROS), which play a fundamental role in endothelial dysfunction and in the nuclear transport of pro-atherogenic transcription factors that activate the "inflammasome". In addition, the glycemic alteration favors the formation and stabilization of atherosclerotic plaque through the mechanism of non-enzymatic glycation of different molecules, with the establishment of the so-called "advanced glycosylation end products" (AGE). Laboratory information provided by the level of bio…

0301 basic medicineBlood GlucoseNovel biomarkersDisease030204 cardiovascular system & hematologyBioinformatics03 medical and health scienceschemistry.chemical_compound0302 clinical medicineGlycationRisk FactorsDiabetes mellitusType 2 diabetes mellitusMedicineHumansEndothelial dysfunctionRisk factorMolecular BiologyGlycemicInflammationGlycationbusiness.industryType 2 Diabetes Mellitusmedicine.diseaseCardiovascular risk030104 developmental biologychemistryDiabetes Mellitus Type 2Cardiovascular DiseasesOxidative stressMolecular MedicineAdvanced glycation end-productbusinessReactive Oxygen SpeciesBiomarkers
researchProduct

Analysis of platelet function and dysfunction.

2014

SummaryAlthough platelets act as central players of haemostasis only their cross-talk with other blood cells, plasma factors and the vascular compartment enables the formation of a stable thrombus. Multiple activation processes and complex signalling networks are responsible for appropriate platelet function. Thus, a variety of platelet function tests are available for platelet research and diagnosis of platelet dysfunction. However, universal platelet function tests that are sensitive to all platelet function defects do not exist and therefore diagnostic algorithms for suspected platelet function disorders are still recommended in clinical practice.Based on the current knowledge of human p…

0301 basic medicineBlood PlateletsPlatelet Function TestsPlatelet dysfunctionPoint-of-care testingPoint-of-Care SystemsVascular compartment030204 cardiovascular system & hematologySensitivity and Specificity03 medical and health sciences0302 clinical medicineThrombinmedicineHumansPlateletThrombusbusiness.industryReproducibility of ResultsHematologymedicine.disease030104 developmental biologyPlatelet function testImmunologyBlood Platelet DisordersbusinessFunction (biology)medicine.drugHamostaseologie
researchProduct

Comparison of platelet function tests for the in vitro quality assessment of platelet concentrates produced under real-life conditions.

2018

Platelet quality in different platelet concentrates (PCs) has been the subject of several studies. Nonetheless, there is a lack of robust data on the correlation and agreement among platelet function tests as a prerequisite for the association of PC functionality in vitro with platelet function in vivo post PC transfusion. The purpose of our study was to correlate a larger panel of platelet function assays in PCs and to assess whether the methods agree sufficiently and can be used interchangeably. Twelve apheresis platelet concentrates in plasma (APC), 16 pooled platelet concentrates in plasma (PPC), and 12 PPC in T-sol (PPCA) were examined on days 1 and 4 after production. PCs were tested …

0301 basic medicineBlood PlateletsPlatelet Function TestsQuality assessmentbusiness.industryPlatelet Countmedia_common.quotation_subjectmacromolecular substancesHematologyGeneral Medicine030204 cardiovascular system & hematologyIn Vitro Techniqueshumanities03 medical and health sciences030104 developmental biology0302 clinical medicinePlatelet function testMedicineHumansQuality (business)Plateletbusinessmedia_commonBiomedical engineeringPlatelets
researchProduct

Peculiarities of studying the effects of pathogen reduction technologies on platelets.

2016

The transfusion of platelet concentrates (PCs) is mainly used for treatment of thrombocytopenic, trauma or surgery patients. The integrity and safety of these platelet preparations, however, is compromised by the presence of pathogens, such as viruses, bacteria and parasites. The transfer of allogeneic donor leukocytes contaminating PCs can also potentially cause adverse reactions in recipients. These considerations prompted the development and implementation of pathogen reduction technologies (PRT), which are based on chemically induced cross-linking and inactivation of nucleic acids. While the incumbent PRT may provide some protection against transfusion-transmitted infections, they are i…

0301 basic medicineBlood PlateletsProteomicsmedicine.medical_specialtyFuture studiesClinical BiochemistryBlood preservationfood and beveragesPathogen reductionTransfusion medicine030204 cardiovascular system & hematologyBiology03 medical and health sciencesFunctional integrity030104 developmental biology0302 clinical medicineBlood PreservationImmunologymedicineAnimalsHumansPlateletBlood TransfusionPlatelet concentrateTranscriptomeProteomics. Clinical applications
researchProduct